Vaccination

Tissue resident memory T cells contribute to protection against heterologous SARS-CoV-2 challenge

by admin | Oct 15, 2024 | Scientific reports, Vaccination, Virology, Pathophysiology

By Abby Odle et al. Source JCI Insight This study found that mice previously infected with recent SARS-CoV-2 variants like Omicron were protected...

COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says

by admin | Sep 27, 2024 | Scientific reports, Vaccination, Virology, Pathophysiology

By Katherine Kahn Source Medpagetoday The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against...

Stroke risks in patients with COVID‐19: multiple mechanisms of SARS‐CoV‐2, impact of sex and age, vaccination, and long‐term infection

by admin | Sep 20, 2024 | Clinical Practice Guidelines, Long Covid19, Vaccination

By Moawiah M. Naffaa et al. Source Springer Abstract The COVID-19 pandemic has presented unprecedented challenges to the healthcare system,...

Heterogeneity of SARS-CoV-2 immune responses after the nationwide Omicron wave in China

by admin | Sep 17, 2024 | Evidence-Based Research in Western Medicine Clinical Practice, Scientific reports, Vaccination

By Jing Wu et al. Source ASM ABSTRACT It remains unclear how previous infections and vaccinations influenced and shaped heterogeneous immune...

Association of COVID-19 Vaccination with Risk of Medically-Attended Post-Acute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras

by admin | Aug 28, 2024 | Research Materials on Influenza and Coronaviral Prevention and Treatment, Scientific reports, Vaccination

By Melanie D Swift et al. Source Oxford academic Structured Abstract Background Uncertainty exists regarding the effectiveness of COVID-19 vaccine...

Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago

by admin | Aug 5, 2024 | Vaccination

By Fabiola Moreno EchevarriaI et al. Source PLOS ONE SARS-CoV-2 vaccines are safe and effective against infection and severe COVID-19 disease...

Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies

by admin | Aug 1, 2024 | Vaccination

By Margherita Bellucci et al. Source Frontiers Introduction: A potential overlap in symptoms between post-acute COVID-19 syndrome and post-COVID-19...